Mauricette Michallet

4PUBLICATIONS
82CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 17, 2026
Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry.

|Mar 25, 2026
Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.

Urbain Tauveron-Jalenques, Gaspar Aspas Requena, Zofia Gross

|Apr 02, 2024
An Integrated Cancer Prevention Strategy: the Viewpoint of the Leon Berard Comprehensive Cancer Center Lyon, France.

Beatrice Fervers, Olivia Pérol, Christine Lasset

|Oct 06, 2022
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.

Vincent Marmouset, Justine Decroocq, Sylvain Garciaz

Pageof 1

Frequent Collaborators

3 joint publications

Emmanuelle Tavernier

2 joint publications

Amine Belhabri

2 joint publications

Gaspar Requena Aspas

2 joint publications

Urbain Tauveron-Jalenques